Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Editorial

Starting the journey: Understanding the roles of complement proteins in liver diseases through mendelian randomization

Mohammad Saeid Rezaee-Zavareh, Naomy Kim, Ju Dong Yang

Clin Mol Hepatol. 2024;30(2):150-153. Published online February 22, 2024

DOI: https://doi.org/10.3350/cmh.2024.0116

View: 2815 Download: 76 Web of Science: 3 Crossref: 2

Original Article

Protein-centric omics analysis reveals circulating complements linked to non-viral liver diseases as potential therapeutic targets

Yingzhou Shi, Hang Dong, Shiwei Sun, Xiaoqin Wu, Jiansong Fang, Jianbo Zhao, Junming Han, Zongyue Li, Huixiao Wu, Luna Liu, Wanhong Wu, Yang Tian, Guandou Yuan, Xiude Fan, Chao Xu

Clin Mol Hepatol. 2024;30(1):80-97. Published online December 7, 2023

DOI: https://doi.org/10.3350/cmh.2023.0343

View: 4304 Download: 205 Web of Science: 2 Crossref: 2

Review

A decade of liver organoids: Advances in disease modeling

Yue Liu, Jian-Ying Sheng, Chun-Fang Yang, Junjun Ding, Yun-Shen Chan

Clin Mol Hepatol. 2023;29(3):643-669. Published online March 6, 2023

DOI: https://doi.org/10.3350/cmh.2022.0428

View: 9278 Download: 293 Web of Science: 2 Crossref: 3

Wnt signaling in liver regeneration, disease, and cancer

Gengyi Zou, Jae-Il Park

Clin Mol Hepatol. 2023;29(1):33-50. Published online July 4, 2022

DOI: https://doi.org/10.3350/cmh.2022.0058

View: 6640 Download: 271 Web of Science: 15 Crossref: 15

Subclinical versus advanced forms of alcohol-related liver disease: Need for early detection

Concepción Gómez-Medina, Luma Melo, David Martí-Aguado, Ramón Bataller

Clin Mol Hepatol. 2023;29(1):1-15. Published online April 15, 2022

DOI: https://doi.org/10.3350/cmh.2022.0017

View: 9765 Download: 185 Web of Science: 5 Crossref: 6

Letter to the Editor

The major diagnostic role of autoantibodies in the diagnosis of autoimmune hepatitis, a disease of all ages

Linda Beenet

Clin Mol Hepatol. 2021;27(3):510-511. Published online March 22, 2021

DOI: https://doi.org/10.3350/cmh.2021.0058

View: 4126 Download: 160 Web of Science: 1 Crossref: 1

Original Article

Loss-of-function HSD17B13 variants, non-alcoholic steatohepatitis and adverse liver outcomes: Results from a multi-ethnic Asian cohort

Yi-Wen Ting, Amanda Shen-Yee Kong, Shamsul Mohd Zain, Wah-Kheong Chan, Hwa-Li Tan, Zahurin Mohamed, Yuh-Fen Pung, Rosmawati Mohamed

Clin Mol Hepatol. 2021;27(3):486-498. Published online February 23, 2021

DOI: https://doi.org/10.3350/cmh.2020.0162

View: 6175 Download: 261 Web of Science: 21 Crossref: 23

Special topic: Alcoholic liver diseases The 14th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPDC)

Long non-coding RNAs in liver diseases: Focusing on nonalcoholic fatty liver disease, alcohol-related liver disease, and cholestatic liver disease

Sen Han, Ting Zhang, Praveen Kusumanchi, Nazmul Huda, Yanchao Jiang, Zhihong Yang, Suthat Liangpunsakul

Clin Mol Hepatol. 2020;26(4):705-714. Published online October 1, 2020

DOI: https://doi.org/10.3350/cmh.2020.0166

View: 4923 Download: 98 Web of Science: 11 Crossref: 10

Roles of the complement system in alcohol-induced liver disease

Yi Zhou, Guandou Yuan, Fudi Zhong, Songqing He

Clin Mol Hepatol. 2020;26(4):677-685. Published online October 1, 2020

DOI: https://doi.org/10.3350/cmh.2020.0094

View: 7139 Download: 145 Web of Science: 12 Crossref: 13

Liver-lung axes in alcohol-related liver disease

Gavin E. Arteel

Clin Mol Hepatol. 2020;26(4):670-676. Published online October 1, 2020

DOI: https://doi.org/10.3350/cmh.2020.0174

View: 6082 Download: 129 Web of Science: 10 Crossref: 9

Programmed cell death in alcohol-associated liver disease

Tatsunori Miyata, Laura E. Nagy

Clin Mol Hepatol. 2020;26(4):618-625. Published online September 21, 2020

DOI: https://doi.org/10.3350/cmh.2020.0142

View: 11220 Download: 278 Web of Science: 45 Crossref: 48

Original Article

Clinical outcomes of coronavirus disease 2019 in patients with pre-existing liver diseases: A multicenter study in South Korea

Yu Rim Lee, Min Kyu Kang, Jeong Eun Song, Hyun Jung Kim, Young Oh Kweon, Won Young Tak, Se Young Jang, Jung Gil Park, Changhyeong Lee, Jae Seok Hwang, Byoung Kuk Jang, Jeong Ill Suh, Woo Jin Chung, Byung Seok Kim, Soo Young Park

Clin Mol Hepatol. 2020;26(4):562-576. Published online October 1, 2020

DOI: https://doi.org/10.3350/cmh.2020.0126

View: 6891 Download: 183 Web of Science: 22 Crossref: 23

Review

Fecal microbiota transplantation in alcohol related liver diseases

Saggere Muralikrishna Shasthry

Clin Mol Hepatol. 2020;26(3):294-301. Published online June 23, 2020

DOI: https://doi.org/10.3350/cmh.2020.0057

View: 7561 Download: 222 Web of Science: 23 Crossref: 25

Hepatic venous pressure gradient: clinical use in chronic liver disease

Ki Tae Suk

Clin Mol Hepatol. 2014;20(1):6-14. Published online March 26, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.1.6

View: 17453 Download: 362 Web of Science: 99 Crossref: 94

3

The usefulness of transient elastography to diagnose cirrhosis in patients with alcoholic Liver disease

Sang Gyune Kim, M.D., Young Seok Kim, M.D., Seung Won Jung, M.D., Hee Kyung Kim, M.D. Jae Young Jang, M.D., Jong Ho Moon, M.D., Hong Soo Kim, M.D., Joon Seong Lee, M.D., Moon Sung Lee, M.D., Chan Sup Shim, M.D., Boo Sung Kim, M.D.

Clin Mol Hepatol. 2009;15(1):42-51. Published online March 31, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.1.42

View: 6556 Download: 126 Crossref: 25

Validation of the Korean Version of Liver Disease Quality of Life (LDQOL 1.0) Instrument

Sehyun Kim, Ph.D. Ki Hyun Choi, M.D. Seong Gyu Hwang, M.D. Ji Hyun Lee, M.D. Sun Young Kwak, M.D. Pil Won Park, M.D. Yukyung Kim, M.D. Hye Ja Park, Ph.D. Soon Joo Kim, M.A. Kyu Sung Rim M.D.

Clin Mol Hepatol. 2007;13(1):44-50. Published online January 1, 1970

View: 3001 Download: 67

Distinct Expressions of TGF - α among Chronic Hepatitis , Liver Cirrhosis , and Hepatocellular Carcinoma

Byeong Moo Yoo , Sung Soo Park , Dong Hoo Lee , Jung Dal Lee

Clin Mol Hepatol. 1997;3(4):316-328.

View: 2279 Download: 12

The Detection of Hepatitis G Virus RNA by RT - PCR in Various Liver Diseases

Kwang Hyub Han , Won Choi , Young Nyun Park , Young Woong Hwang , Wang Sik Ryu , Eun Sin Park , Kwan Sik Lee , Chae Yoon Chon , Young Myoung Moon , Chan Il Park

Clin Mol Hepatol. 1997;3(2):123-132.

View: 2619 Download: 21

A Study on the Efficacy and Safety of Dipheny - dimethyl - dicarboxylate in Patients with Chronic Liver disease

Hyoung Sik kim , Soo Taek Lee , Dae Gon kim , Deuk Soo Ahn

Clin Mol Hepatol. 1996;2(1):54-60.

View: 3572 Download: 101

Evaluation of Angiogenin Concentrations using ELISA in Sera from the Patients with Chronic Liver Diseases.

Kee Woon Kweon, Soong Hwan Lee, Seong Hee Lee, Hong Ju Kim, Chang Hwa Lee, Byoung Hun Kim, In Kyu Paik, Dong Il Park, Sung Soo Park, Dong Hoo Lee

Clin Mol Hepatol. 1996;2(1):29-36. Published online January 1, 2000

View: 58007 Download: 16

Clinical Significance of the Correlation of Serum ProcollagenⅠand Ⅲ Propeptide Concentrations in Chronic Liver Diseases

Dong Il Park , Soong Hwan Lee , In Kyu Paik , Yong Hyeon Cho , Yun hu Cho , Byoung Hun kim , Dong Hoo lee

Clin Mol Hepatol. 1996;2(1):13-20.

View: 2370 Download: 11

Correspondence

Correspondence to editorial on “Protein-centric omics analysis reveals circulating complements linked to non-viral liver diseases as potential therapeutic targets”

Yingzhou Shi, Guandou Yuan, Xiude Fan, Chao Xu

Received April 16, 2024 Accepted April 19, 2024

DOI: https://doi.org/10.3350/cmh.2024.0266 [Epub ahead of print]

View: 593 Download: 22

Reply to Correspondence

Reply to correspondence on “Protein-centric omics analysis reveals circulating complements linked to non-viral liver diseases as potential therapeutic targets”

Mohammad Saeid Rezaee-Zavareh, Naomy Kim, Ju Dong Yang

Received April 30, 2024 Accepted April 30, 2024

DOI: https://doi.org/10.3350/cmh.2024.0320 [Epub ahead of print]

View: 660 Download: 43

Review

Current status and perspective on molecular targets and therapeutic intervention strategy in hepatic ischemia-reperfusion injury

Jia Liu, Ranyi Luo, Yinhao Zhang, Xiaojiaoyang Li

Received April 3, 2024 Accepted June 26, 2024

DOI: https://doi.org/10.3350/cmh.2024.0222 [Accepted]

View: 868 Download: 121

Review Article

Immunological mechanisms in steatotic liver diseases: An overview and clinical perspectives

Mengyao Yan, Shuli Man, Long Ma, Lanping Guo, Luqi Huang, Wenyuan Gao

Received April 28, 2024 Accepted July 10, 2024

DOI: https://doi.org/10.3350/cmh.2024.0315 [Accepted]

View: 607 Download: 72

1 |

Viewed By 5858	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 5294	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 4996	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4995	MAFLD: How is it different from NAFLD?
Viewed By 4615	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 203	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 143	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 119	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 103	MAFLD: How is it different from NAFLD?
Cited By 93	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search